IOVANCE BIOTHERAPEUTICS, INC. Increase (Decrease) in Other Operating Assets
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Increase (Decrease) in Other Operating Assets of -$16.00 thousand for the 51-month period ending 2011-12-31, per its 10-K filed 2012-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2012-03-30
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2011-12-31 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2010-12-31 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2011 was -$16.00K.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2010 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2009 was $0.00.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 48 month | Increase (Decrease) in Other Operating Assets 51 month |
|---|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$16.00K 10-K · filed 2012-03-30 | -$16.00K 10-K · filed 2012-03-30 | ||
| 2011-09-30 | -$16.00K 10-Q · filed 2011-11-21 | -$16.00K 10-Q · filed 2011-11-21 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $0.00 10-K · filed 2012-03-30 | |||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-21 | ||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |